Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

March 3, 2025

Study Completion Date

June 30, 2026

Conditions
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Interventions
DRUG

evorpacept

IV Q3W

DRUG

pembrolizumab

IV Q3W

DRUG

Cisplatin/Carboplatin; 5FU

IV Q3W

Trial Locations (44)

1081

Amsterdam UMC, Locatie VUMC, Amsterdam

2850

Grupo Hospital de Madrid (HM) - Hospital Universitario Madrid Sanchinarro - Cent, Madrid

3000

Peter MacCallum Cancer Centre, Melbourne

3080

Seoul National University Hospital, Seoul

3722

Severance Hospital, Yonsei University Health System, Seoul

4029

Royal Brisbane and Womens Hospital, Herston

5037

Ashford Cancer Centre, Adelaide

6009

Sir Charles Gairdner Hospital, Nedlands

6351

Samsung Medical Center, Seoul

8500

AZ Groeninge, Kortrijk

9713

Universitair Medisch Centrum Groningen, Groningen

10021

Memorial Sloan Kettering, New York

13496

CHA University - Bundang CHA General Hospital (CHA Bundang Medical Center), Seongnam-si

13620

Seoul National University, Bundang Hospital, Seongnam

21201

University of Maryland Medical System, Baltimore

21565

Gachon University (GCU) - Gil Medical Center (Gil Hospital), Incheon

28644

Chungbuk National University Hospital, Cheongju-si

28911

Hospital Universitario Severo Ochoa, Leganés

29011

Hospital Regional Universitario de Malaga, Málaga

31008

Hospital Universitario de Navarra, Pamplona

33136

University of Miami, Sylvester Comprehensive Cancer Center, Miami

33612

Moffitt Cancer Center, Tampa

37232

Vanderbilt - Ingram Cancer Center, Nashville

40202

University of Louisville, Louisville

42415

Yeungnam University Medical Center, Daegu

43235

The Ohio State University, Columbus

60612

Rush University Medical Center, Chicago

77030

Houston Methodist Cancer Center, Houston

90048

Cedar Sinai Medical Center, Los Angeles

92037

University of California San Diego, La Jolla

92618

Hoag Hospital, Irvine

97239

Oregon Health & Science University/ Knight Cancer Institute, Portland

119074

National University Cancer Institute, Singapore

168583

National Cancer Centre Singapore, Singapore

Unknown

Cliniques Universitaires Saint-Luc, Brussels

Hospital Universitario La Paz, Madrid

03312

The Catholic University of Korea - Eunpyeong St. Mary's Hospital, Seoul

07061

Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center, Seoul

08028

Hospital Universitari Dexeus, Barcelona

08916

Institut Catala d Oncologia (ICO), Badalona

08908

Institut Catala dOncologia, L'Hospitalet de Llobregat

5PT

The Royal Marsden Hospital - Surrey, London

University College London Hospital, London

6JJ

The Royal Marsden Hospital- London, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

ALX Oncology Inc.

INDUSTRY